Insider · CIK 0001815678
Andong Huang
Files at OTLK (Outlook Therapeutics, Inc.). First filing -, latest -.
Andong Huang files SEC Form 4 as director at OTLK (Outlook Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Andong Huang has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2025 | OTLK Outlook Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +286,734 | $0.00 | $0 | 286,734 | Oct 3, 2025 |
| Oct 3, 2025 | OTLK Outlook Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +53,316 | $0.00 | $0 | 53,316 | Oct 3, 2025 |
Questions about Andong Huang
Answered from the filings on this page, as of the latest one.
Is Andong Huang buying or selling?
Andong Huang has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Andong Huang's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Andong Huang has 0.
Where does Andong Huang file Form 4?
Andong Huang has filed Form 4 at OTLK (Outlook Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.